MRS: An AI-supported risk-staging system for newly diagnosed multiple myeloma patients (2021)
What is it used for?
Modified Risk Staging (MRS) calculator is a robust AI-enabled risk-staging system for upfront risk stratification of newly diagnosed multiple myeloma (NDMM) patients. It is an efficient and readily employable risk prognostication method which is beneficial for the settings where genomics tests cannot be performed owing to geographical/economical constraints.
How does it work?
It predicts the risk stage of a patient depending on the values of the key prognostic parameters- age, albumin, β2-microglobulin (β2m), hemoglobin, calcium and estimated glomerular filtration rate (eGFR). Risk stage is predicted based on the classification rules obtained via decision tree classifier. A screenshot of the MRS calculator along with the decision tree classification rules, is shown below.
Please acknowledge the related publication by including the following citation in your work:
Akanksha Farswan, Anubha Gupta, Ritu Gupta, Saswati Hazra, Sadaf Khan, Lalit Kumar, and Atul Sharma, “AI-Supported Modified Risk Staging for Multiple Myeloma Cancer useful in real-world scenario,” Translational Oncology, Elsevier, vol. 14, no. 9, article no. 101157, pp. 1-9, September 2021, doi: 10.1016/j.tranon.2021.101157. (2021 IF: 4.243) [PDF] [Calculator]
Access to the calculator here